Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background In women with chronic schizophrenia, higher levels of peripheral oxytocin have been associated with lower levels of positive but not negative symptoms. Sex-specific associations between endogenous levels of oxytocin (OT) and arginine-vasopressin (AVP) with clinical symptoms and cognition in untreated early course patients have not been examined. Method Clinical ratings and neuropsychological testing were performed in thirty-eight acutely ill, unmedicated first-episode schizophrenia patients (14 women, 24 men). Serum hormone assays were obtained in patients and thirty-eight demographically similar healthy controls. Results Patients demonstrated increased AVP levels compared to controls (p=0.01). Higher AVP levels were associated with greater positive symptoms (r=0.58, p=0.03) and worse verbal learning (r=−0.63, p=0.02) in female, but not male, patients. OT levels did not statistically differ between patients and controls, and were unrelated to clinical symptoms or cognition in patients. Conclusion Results suggest an association of endogenous AVP with increased positive symptom severity and worse cognition in untreated female, but not male, schizophrenia patients. Findings support the role of neuroendocrine alterations in acute psychosis and the importance of examining sex-specific neuroendocrine alterations early in the course of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 2×
“AVP is also released centrally during stressful experiences (Landgraf et al., 1998) and is implicated in the regulation of the hypothalamic-pituitary adrenal (HPA) axis, including cortisol secretion (Meyer-Lindenberg et al., 2011).”
BackgroundThe polyvagal theory: phylogenetic substrates of a social nervous system.
Porges, S. W. (2001) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(01)00162-3 · Cited by 1,582 · cited 2×
“Mechanisms by which OT may have therapeutic effects on clinical symptoms could involve modulation of emotional regulation and the autonomic nervous system (Porges, 2001) and neurochemical systems dependent on dopamine and/or glutamate (Caldwell et al., Schizophr Res.”
BackgroundNeuroendocrine perspectives on social attachment and love
Sue Carter, C. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00055-9 · Cited by 1,425
Landgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059
Oxytocin, vasopressin, and human social behavior
Heinrichs, M., von Dawans, B., & Domes, G. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.005 · Cited by 799 · cited 3×
“Whereas OT influences stress management, cardiovascular regulation, and under some conditions may have amnestic effects on verbal learning and memory; AVP is more typically associated with vigilance, mobilization, increased reactivity to stressors, and improvements in verbal learning and memory (Carter, 1998; Carter e…”
BackgroundJardri, R., Pouchet, A., Pins, D., & Thomas, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101522 · Cited by 651 · cited 2×
“, 2005); which are critical areas for emotion, cognition, and positive symptoms in schizophrenia (Jardri et al., 2011; Kuperberg and Heckers, 2000).”
BackgroundLower CSF oxytocin concentrations in women with a history of childhood abuse
Heim, C., Young, L. J., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.112 · Cited by 518 · cited 1×
“There are previous reports that the beneficial or “antistress” effect of OT is most apparent in response to chronic stressors such as isolation or adversity (Grippo et al., 2009; Heim et al., 2009; Penza et al., 2003).”
BackgroundGlutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Oxytocin, vasopressin and sociality
CARTER, C., GRIPPO, A., POURNAJAFINAZARLOO, H., RUSCIO, M., & PORGES, S. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00427-5 · Cited by 380 · cited 3×
“Whereas OT influences stress management, cardiovascular regulation, and under some conditions may have amnestic effects on verbal learning and memory; AVP is more typically associated with vigilance, mobilization, increased reactivity to stressors, and improvements in verbal learning and memory (Carter, 1998; Carter e…”
BackgroundSelf-citationOxytocin–dopamine interactions mediate variations in maternal behavior in the rat
Shahrokh, D. K., Zhang, T.-Y., Diorio, J., Gratton, A., & Meaney, M. J. (2010) · Endocrinology · doi:10.1210/en.2009-1271 · Cited by 366
The neural correlates of sex differences in emotional reactivity and emotion regulation
Domes, G., Schulze, L., Böttger, M., Grossmann, A., Hauenstein, K., Wirtz, P. H., Heinrichs, M., & Herpertz, S. C. (2010) · Human Brain Mapping · doi:10.1002/hbm.20903 · Cited by 347
Oxytocin: Behavioral Associations and Potential as a Salivary Biomarker
SUE CARTER, C., POURNAJAFI‐NAZARLOO, H., KRAMER, K. M., ZIEGLER, T. E., WHITE‐TRAUT, R., BELLO, D., & SCHWERTZ, D. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1384.006 · Cited by 323 · cited 1×
“OT and AVP were quantified with an EIA kit (Enzo Life Sciences/Assay Designs); as validated for OT and AVP (Carter et al., 2007).”
MethodSelf-citationSex-specific influences of vasopressin on human social communication
Thompson, R. R., George, K., Walton, J. C., Orr, S. P., & Benson, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600406103 · Cited by 312
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients
Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308
Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · cited 1×
“Pharmacological studies administering exogenous OT to predominantly chronic male patients also suggest short-term benefits for positive and negative symptoms and social cognition (Averbeck et al., 2011; Feifel et al., 2010; Goldman et al., 2011; Pedersen et al., 2011).”
Backgroundvan Leeuwen, F. W., Caffe, A. R., & Vries, G. J. D. (1985) · Brain Research · doi:10.1016/0006-8993(85)90348-8 · Cited by 248
Grippo, A. J., Trahanas, D. M., Zimmerman, R. R., Porges, S. W., & Carter, C. S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.017 · Cited by 240
Self-citationDissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress
Gibbs, D. M. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90241-8 · Cited by 233 · cited 2×
“It is also important to note that not all stressors stimulate both OT and AVP release in animals or humans (Gibbs, 1984; Altemus et al., 1995, 2001; Jezova et al., 1995).”
BackgroundRyan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225 · cited 2×
“This finding is consistent with Raskind (1978), but inconsistent with other studies reporting lower peripheral (Legros et al., 1992; Ryan et al., 2004) and central AVP levels (Linkowski et al., 1984) in schizophrenia compared to controls (cf., Beckmann et al., 1985; Walsh et al., 2005).”
ResultOxytocin revisited: Its role in cardiovascular regulation
Gutkowska, J., & Jankowski, M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02235.x · Cited by 208 · cited 2×
“Whereas OT influences stress management, cardiovascular regulation, and under some conditions may have amnestic effects on verbal learning and memory; AVP is more typically associated with vigilance, mobilization, increased reactivity to stressors, and improvements in verbal learning and memory (Carter, 1998; Carter e…”
BackgroundRosenfeld, A. J., Lieberman, J. A., & Jarskog, L. F. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq015 · Cited by 178 · cited 2×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript 2009; Feifel and Reza, 1999; Qi et al., 2008; Rosenfeld et al., 2011; Sarnyai and Kovacs, 1994; Shahrokh et al., 2010).”
BackgroundSex differences in vasopressin and oxytocin innervation of the brain
DEVRIES, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00402-0 · Cited by 169
Sharing secrets: oxytocin and trust in schizophrenia
Kéri, S., Kiss, I., & Kelemen, O. (2009) · Social Neuroscience · doi:10.1080/17470910802319710 · Cited by 167 · cited 2×
“, 1984) and peripheral levels (Goldman et al., 2008; Keri et al., 2009) of OT in most but not all studies (Glovinsky et al.”
BackgroundVeenema, A. H., Bredewold, R., & De Vries, G. J. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.002 · Cited by 129
Qi, J., Yang, J.-Y., Song, M., Li, Y., Wang, F., & Wu, C.-F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0245-8 · Cited by 129 · cited 2×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript 2009; Feifel and Reza, 1999; Qi et al., 2008; Rosenfeld et al., 2011; Sarnyai and Kovacs, 1994; Shahrokh et al., 2010).”
BackgroundGoldman, M. B., Gomes, A. M., Carter, C. S., & Lee, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2193-8 · Cited by 112 · cited 1×
“Pharmacological studies administering exogenous OT to predominantly chronic male patients also suggest short-term benefits for positive and negative symptoms and social cognition (Averbeck et al., 2011; Feifel et al., 2010; Goldman et al., 2011; Pedersen et al., 2011).”
BackgroundSanders, G. (1990) · Psychoneuroendocrinology · doi:10.1016/0306-4530(90)90046-c · Cited by 86
Ruscio, M. G., Sweeny, T., Hazelton, J., Suppatkul, P., & Sue Carter, C. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.08.004 · Cited by 81 · cited 1×
“Animal studies suggest various forms of stress may increase the synthesis and release of AVP (Ma and Lightman, 1998; Neumann et al., 2006; Ruscio et al., 2007; Todeschin et al., 2009).”
BackgroundFunctional magnetic resonance imaging and the neurobiology of vasopressin and oxytocin
FERRIS, C. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00425-1 · Cited by 75
Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/−) reeler mice
Liu, W., Pappas, G. D., & Carter, C. S. (2005) · Neurological Research · doi:10.1179/016164105x35602 · Cited by 73 · cited 2×
“…schizophrenia, haplo-insufficient reeler mice show reductions in OT receptors in regions of the hippocampus and retrosplenial and piriform cortex (Liu et al., 2005); which are critical areas for emotion, cognition, and positive symptoms in schizophrenia (Jardri et al., 2011; Kuperberg and…”
BackgroundSelf-citationLevin, R., Heresco-Levy, U., Bachner-Melman, R., Israel, S., Shalev, I., & Ebstein, R. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.014 · Cited by 68 · cited 1×
“Polymorphisms in genes in the AVP pathway have been associated with schizophrenia (Feifel and Priebe, 2001; Levin et al., 2009; Teltsh et al., 2011), possibly accounting for some of the observed variations in outcomes among the studies in this field.”
ResultOxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions
Feifel, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.184 · Cited by 42 · cited 1×
“Animal and human studies suggest that abnormalities in OT may contribute to the clinical presentation of schizophrenia (for reviews, Feifel, 2011, 2012).”
Background
Cited by
Walton, E., Hass, J., Liu, J., Roffman, J. L., Bernardoni, F., Roessner, V., Kirsch, M., Schackert, G., Calhoun, V., & Ehrlich, S. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv074 · Cited by 286
Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., Palombini, E., Dell’Osso, L., Caverzasi, E., Politi, P., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.117 · Cited by 149
Oxytocin׳s role in anxiety: A critical appraisal
MacDonald, K., & Feifel, D. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.025 · Cited by 139
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Drogos, L. L., Hill, S. K., Ruocco, A. C., Keedy, S. K., Reilly, J. L., Keshavan, M. S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu027 · Cited by 127
Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients
Jobst, A., Dehning, S., Ruf, S., Notz, T., Buchheim, A., Henning-Fast, K., Meißner, D., Meyer, S., Bondy, B., Müller, N., et al. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.20 · Cited by 89
Metadata
- Authors
- Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Harris, M. S. H., Hill, S. K., Reilly, J. L., & Sweeney, J. A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 146
- Issue
- 1-3
- Pages
- 138-143
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W1978371403
- Cited by
- 66
- References
- 32
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.